CD274 and neoplasm: Furthermore, PD-L1/CD274 silencing on DC could enhance T-cell responses leading to tumor clearance [2], which is in accordance with several studies demonstrating the advantages of knocking down PD-L1/CD274 regarding the efficacy of DC vaccine therapy [27,28].